Get Data Management Tips from ClinCapture’s Halloween LIVE Event

9 December, 2025, by Jacob Roach

“My final question is for you Doctor, how do you spell TRIALZ?” Scott Weidley asked Dr. Geeta Nayyar, Salesforce’s Chief Medical Officer, as he wrapped up a discussion between five industry leaders in the clinical trial and digital health space. The event “Halloween LIVE – No Tricks just Treats from Data Management Experts” premiered live on Friday, October 28th and is now available for streaming here. 

The panel was hosted by ClinCapture’s CEO and President, Scott Weidley, and consisted of Amanda McLean, Director of Sales at ClinCapture, Geeta Nayyar, Chief Medical Officer at Salesforce, Brad Hightower, CEO of Hightower Clinical, and Nico O’Kuingttons, VP of Decentralized Trials at Huma. The show kicked off with a discussion based around larger health companies getting involved in the clinical trial space, Geeta had this to add, “There’s a lot of space for opportunity in the clinical trial space. In the healthcare space in general…There are so many differences in fractured parts of the system, one of them being clinical trials.”

The discussion then shifted to the future of the clinical space, Geeta discussed diversity in the space “I think that we’re all appreciating that there needs to be more diversity in trials that reflect the patient populations that we actually treat right… And an understanding of certain diseases that are genetically predisposed to certain populations.”

As the event closed, the last major topic discussed by the panel was the lasting impact COVID-19 had on the way that clinical trials are conducted with Brad Hightower offering what he saw on a site level: 

“A little bit of a mixed bag, but there was definitely a strong shift from the sponsors trying to support the site so that they could keep their current patients in trials and on drugs as much as possible.” Then, Nico O’Kuinghttons chimed in with what he saw, “I think there was a lot of panic with trials that were mid-flight that was number one. You know, you have a trial that is 50% of the way through and now you have to think about how you’re going to collect the data of your current participants.” This remark was followed by Amanda McLean closing the topic by giving her first hand insight to what eClinical software she has seen being used more and more since the pandemic, “ eConsent specifically – pharma companies, medical device, biotech, almost all of them at least ask about it. ePRO has been used for a long time…that’s kind of been the norm… eConsent specifically though, it may not be implemented right now, but there may be a near future where you do see that more.”

Enjoy the entire LIVE show here to get the entire discussion from top voices in the healthcare and clinical trial industry and find out the right way to spell TRIALZ.